Description
Specifications
| Clone | IHC538 |
| Source | Mouse Monoclonal |
| Positive Control | Tonsil, Lymph Node |
| Dilution Range | 1:200 |
Cluster of differentiation 5 (CD5) is expressed in high levels on the surface of T cells, while controversy surrounds the expression levels and role of CD5 in B cells. As a part of a diagnostic panel, its utility lies predominantly as a marker for T cells, with over 70% of T cell neoplasms expressing CD5. In particular, it is correlated with chronic lymphocytic leukemia/small lymphocytic lymphomas, mantle cell lymphoma, as well as a subset of diffuse large B cell lymphomas. CD5 demonstrates positive expression in thymic carcinomas, and is not as sensitive as CD3. CD5 also has value as a prognostic indicator, being associated with poor prognosis in acute T cell lymphoblastic leukemia.
| Clone | IHC538 |
| Source | Mouse Monoclonal |
| Positive Control | Tonsil, Lymph Node |
| Dilution Range | 1:200 |
The genesig® Real-Time PCR COVID-19 (CE) is CE-IVD marked and intended for in vitro diagnostic use in Europe.
PLEASE NOTE: This is a Professional Use Only product that requires a trained operator in a controlled laboratory environment. It is NOT a lateral flow or a Point of Care device designed to be used by the general public.
Total workflow solution
All reagents and components provided from start to finish
Rapid protocol with fewer handling steps
For use with dry swabs
Viral inactivation; Preparation, Amplification, Diagnosis
Total chemistry optimisation
Low shipping costs with ambient shipping
Includes our genesig® Real-Time PCR Coronavirus COVID-19 (CE IVD)
Norgen’s Trichomonas vaginalis End-Point PCR Kit is designed for the detection of Trichomonas vaginalis specific DNA based on the use of end-point PCR technology. This kit is designed for research use only and not for use in diagnostic procedures. The kit includes Master Mix and primers for the specific amplification of a 335 nucleotide region of the Trichomonas vaginalis genome, as well as a positive control and a negative control to confirm the integrity of the kit reagents. In addition, the kit contains loading dye and a DNA ladder to facilitate analysis of the results.
The detection of Trichomonas vaginalis specific DNA is based on end-point PCR technology, utilizing polymerase chain reaction (PCR) for the amplification of specific Trichomonas vaginalis DNA sequences. For analysis of the PCR data, the PCR reaction is loaded on an agarose DNA gel along with the provided DNA ladder for qualitative analysis.
Trichomonas vaginalis TaqMan PCR Kit, 100 reactions
Trichomonas vaginalis TaqMan PCR Probe/Primer Set and Controls, 100 reactions
For research use only and NOT intended for in vitro diagnostics.
Figure 1 / 3
Click for expanded view
Storage Conditions and Product Stability
All kit components can be stored for 2 years after the date of production without showing any reduction in performance.
All kit components should be stored at -20°C upon arrival. Repeated thawing and freezing (> 2 x) of the Master Mix and Positive Control should be avoided, as this may affect the performance of the assay. If the reagents are to be used only intermittently, they should be frozen in aliquots.
| Component | Cat. TM52050 (100 preps) | Cat. TM52010 (100 preps) |
|---|---|---|
| MDx TaqMan 2X PCR Master Mix | 2 x 700 μL | – |
| Trichomonas vaginalis Primer & Probe Mix | 280 μL | 280 μL |
| Trichomonas vaginalis Positive Control | 150 μL | 150 μL |
| Nuclease-Free Water (Negative Control) | 1.25 mL | 1.25 mL |
| Product Insert | 1 | 1 |
| Clone | IHC512 |
| Source | Mouse Monoclonal |
| Positive Control | Hairy Cell Leukemia |
| Dilution Range | 1:200 |
Annexin A1 (ANXA1) is a membrane protein that plays a role in innate and adaptive immunity by controlling the biosynthesis of inflammation, prostaglandins, and leukotriene mediators. This target is overexpressed in 97% of all samples from patients with with hairy cell leukemia, and is absent in other B-cell lymphomas. High ANXA1 expression is frequently associated with advanced stage esophageal and esophagogastric junction adenocarcinoma, and is also linked to advanced and metastatic disease states.